Arthur C. Butcher - 03 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP& Grp Pres, MedSurg & APAC
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
03 Feb 2023
Net transactions value
-$1,066,831
Form type
4
Filing time
06 Feb 2023, 15:41:27 UTC
Previous filing
03 Jan 2023
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $176,507 +10,822 +31% $16.31 46,180 03 Feb 2023 Direct
transaction BSX Common Stock Options Exercise $72,699 +4,212 +9.1% $17.26 50,392 03 Feb 2023 Direct
transaction BSX Common Stock Sale $1,316,037 -27,000 -54% $48.74 23,392 03 Feb 2023 Direct F1
holding BSX Common Stock 2,545 03 Feb 2023 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -4,212 -26% $0.000000 11,931 03 Feb 2023 Common Stock 4,212 $17.26 Direct F3
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -10,822 -100% $0.000000* 0 03 Feb 2023 Common Stock 10,822 $16.31 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.70 to $48.78, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.